# A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays

> **NCT02072525** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 359 (actual)

## Conditions studied

- Meningococcal

## Interventions

- **BIOLOGICAL:** Menveo®
- **BIOLOGICAL:** Boostrix®
- **BIOLOGICAL:** Pneumovax 23®
- **BIOLOGICAL:** Prevnar 13®

## Key facts

- **NCT ID:** NCT02072525
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-01
- **Primary completion:** 2015-06-02
- **Final completion:** 2015-06-02
- **Target enrollment:** 359 (ACTUAL)
- **Last updated:** 2017-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02072525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02072525, "A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02072525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*